Eli Lilly Strikes Deal to Acquire Morphic for $3.2 Billion
Under terms of the deal, Lilly is expected to present an offer to acquire all outstanding shares of Morphic for an estimated total of $3.2 billion, with the transaction already approved by the board of directors of both companies. At closing, the purchase price was at a premium of approximately 79.0% to the closing stock price on July 5, 2024, and 87.2% to the 30-day volume-weighted average trading price of Morphic's common stock ended on July 5, 2024, the last trading day before the announcement of the transaction.1"
https://www.pharmexec.com/view/eli-lilly-strikes-deal-acquire-morphic-3-2-billion"
General Comments / Chat, page-11100
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.78 |
Change
0.030(1.71%) |
Mkt cap ! $302.3M | |||
| Open | High | Low | Value | Volume |
| $1.82 | $1.82 | $1.78 | $41.58K | 23.24K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4217 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 850 | 1 |
View Market Depth
| Last trade - 12.48pm 10/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |